RxDoctor Payments DataLook up a doctor →

Vyloy: payments to doctors

Payments that named Vyloy as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.3M
Providers
4,399
Transactions
9,201
Average per transaction
$146

The per-transaction average — $146 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,399 providers the average total is $306, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Astellas Pharma US Inc$1,083,41780.5%
Astellas Pharma Global Development$146,11810.9%
Astellas Pharma Europe Ltd$116,0648.6%
← All drugs & devices